Physician profile
Enrico E Divito
NPI 1487773529
$289,097.45
in general payments reported to CMS, 2019-2025
5 companies · $35K in 2025
The $35K reported for 2025 was more than what 99% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52K · 2020: $30K · 2021: $6,661 · 2022: $34K · 2023: $70K · 2024: $62K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $154K · Travel and Lodging: $8,305 · Education: $2,672 · Food and Beverage: $2,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $154,375.00 |
| Travel and Lodging | $8,304.61 |
| Education | $2,672.40 |
| Food and Beverage | $2,004.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonendo INC | $285,272.71 | 2019-2025 | Gentlewave G4 Console, Posterior Cleanflow Procedure Instrument With Matrices, Gentlewave Console |
| Patterson Companies, INC. | $1,500.00 | 2019 | |
| Sirona Dental, INC. | $1,500.00 | 2019 | |
| Dentsply Sirona INC | $781.20 | 2022-2023 | Cerec |
| Orapharma, A Division of Bausch Health US, LLC | $43.54 | 2025 | Arestin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,998.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Enrico Divito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.